Gå direkt till huvudinnehållet

Sjögrens syndrom

Senast reviderad:
Sakkunnig:
  1. Fox RI. Sjögren's syndrome. Lancet 2005; 366: 321-31. PubMed  
  2. Kruszka P, O'Brian RJ. Diagnosis and management of Sjögren syndrome. Am Fam Physician 2009; 79: 465-70. PMID: 19323359 PubMed  
  3. Bowman SJ, Ibrahim GH, Holmes G, Hamburger J and Ainsworth JR. Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 2004; 33: 39-43. PubMed  
  4. Fox RI, Tornwall J and Michelson P. Current issues in the diagnosis and treatment of Sjögren's syndrome. Curr Opin Rheumatol 1999; 11: 364-71. PubMed  
  5. Pillemer SR, Matteson EL, Jacobsson LT et al. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County. Minnesota, Mayo Clin Proc 2001; 76: 593-9.
  6. Cummins MJ, Papas A, Kammer GM, Fox PC. Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results. Arthritis Rheum 2003; 49: 585-93. PubMed  
  7. Mariette X, Ravaud P, Steinfeld S, et al. Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). Arthritis Rheum 2004; 50: 1270-6. PubMed  
  8. Manoussakis MN, Georgopoulou C, Zintzaras E et al. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum 2004; 50: 882-91. PubMed  
  9. Oxholm P, Asmussen K, Axell T et al. Sjögren's syndrome: terminology. Clin Exp Rheumatol 1995; 13: 693-6. PubMed  
  10. Dafni UG, Tzioufas AG, Staikos P, Skopouli FN and Moutsopoulos HM. Prevalence of Sjögren's syndrome in a closed rural community. Ann Rheum Dis 1997; 56: 521-5. PubMed  
  11. Arnett F. Histocompatibility typing in the rheumatic diseases: diagnostic and prognostic implications. Med Clin North Am 1994; 20: 371-87. PubMed  
  12. Uhlig T, Kvien TK, Jensen JL and Ax T II. Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann Rheum Dis 1999; 58: 415-22. PubMed  
  13. Arnett FC. HLA and autoimmunity in scleroderma (systemic sclerosis). Int Rev Immunol 1995; 12: 107-28. PubMed  
  14. Vitali C. Classification criteria for Sjögren's syndrome. Ann Rheum Dis 2003; 62: 94-5. PubMed  
  15. Pease CT, Shattles W, Barrett NK and Maini RN. The arthropathy of Sjögren's syndrome. Br J Rheumatol 1993; 32: 609-13. PMID: 8339134 PubMed  
  16. Lwin CT, Bishay M, Platts RG, Booth DA and Bowman SJ. The assessment of fatigue in primary Sjögren's syndrome. Scand J Rheumatol 2003; 32: 33-7. PubMed  
  17. Lindvall B, Bengtsson A, Ernerudh J and Eriksson P. Subclinical myositis is common in primary Sjögren's syndrome and is not related to muscle pain. J Rheumatol 2002; 29: 717-25. PubMed  
  18. Bonafede RP, Downey DC and Bennett RM. An association of fibromyalgia with primary Sjögren's syndrome: a prospective study of 72 patients. J Rheumatol 1995; 22: 133-6. PubMed  
  19. Pflugfelder SC. Differential diagnosis of dry eye conditions. Adv Dent Res 1996; 10: 9-12. PubMed  
  20. Kassan SS, Thomas TL, Moutsopoulos HM et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978; 89: 888-92.PMID: 102228 PubMed  
  21. Voulgarelis M, Dafni UG, Isenberg DA and Moutsopoulos HM. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999; 42: 1765-72. PubMed  
  22. Ramos-Casals M, Anaya JM, Garcia-Carrasco M et al. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 2004; 83: 96-106. PubMed  
  23. Roguedas AM, Misery L, Sassolas B, Le Masson G, Pennec YL and Youinou P. Cutaneous manifestations of primary Sjögren's syndrome are underestimated. Clin Exp Rheumatol 2004; 22: 632-6. PubMed  
  24. Quismorio FP Jr. Pulmonary involvement in primary Sjögren's syndrome, Curr Opin Pulm Med 1996; 2: 424-8. PMID: 9363178 PubMed  
  25. Gyongyosi M, Pokorny G and Jambrik Z et al. Cardiac manifestations in primary Sjögren's syndrome. Ann Rheum Dis 1996; 55: 450-4. PubMed  
  26. Andonopoulos AP, Christodoulou J, Ballas C, Bounas A and Alexopoulos D. Autonomic cardiovascular neuropathy in Sjögren's syndrome: a controlled study. J Rheumatol 1998; 25: 2385-8. PubMed  
  27. Gamron S, Barberis G, Onetti CM et al. Mesangial nephropathy in Sjögren's syndrome. Scand J Rheumatol 2000; 29; 65-7. PMID: 10722261 PubMed  
  28. Leppilahti M, Tammela TL, Huhtala H, Kiilholma P, Leppilahti K and Auvinen A. Interstitial cystitis-like urinary symptoms among patients with Sjögren's syndrome: a population-based study in Finland. Am J Med 2003; 115: 62-5. PubMed  
  29. D'Arbonneau F, Ansart S, Le Berre R, Dueymes M, Youinou P and Pennec YL. Thyroid dysfunction in primary Sjögren's syndrome: a long-term followup study. Arthritis Rheum 2003; 49: 804-9. PubMed  
  30. Delalande S, de Seze J, Fauchais AL et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 2004; 83: 280-91. PubMed  
  31. Grant IA, Hunder GG, Homburger HA and Dyck PJ. Peripheral neuropathy associated with sicca complex. Neurology 1997; 48: 855-62. PMID: 9109867 PubMed  
  32. Utset TO, Golden M, Siberry G, Kiri V, Crum RM and Petri M. Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjögren's syndrome. J Rheumatol 1994; 21: 2039-45. PubMed  
  33. Vivino FB, Gala I and Hermann GA. Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol 2002; 29: 938-44. PubMed  
  34. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren's syndrome. Arch Intern Med 2004; 164: 1275-84. PubMed  
  35. Läkemedelsverket www.lakemedelsverket.se  
  36. Belafsky PC and Postma GN. The laryngeal and esophageal manifestations of Sjögren's syndrome. Curr Rheumatol Rep 2003; 5: 297-303. PubMed  
  37. Gottenberg J-E, Ravaud P, Puechal X, et al. Effects of hydroxychloroquine on symptomatic improvement in primary sjøgren syndrom. The JOQUER randomized clinical trial. JAMA 2014; 312: 249-58. doi:10.1001/jama.2014.7682 PMID: 25027140 PubMed  
  38. Deheinzelin D, Capelozzi VL, Kairalla RA, Barbas Filho JV, Saldiva PH and de Carvalho CR. Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 1996; 154: 794-9. PubMed  
  39. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005; 165: 2337-44. PubMed  
  40. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002; 46: 741-7. PubMed  
  • Tomas Zweig, överläkare, Reumatologkliniken, Karolinska Universitetssjukhuset, Solna
  • Anna Nager, med dr och specialist i allmänmedicin, Karolinska institutet